drugset / Trial / NCT00109278

A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)

NCT00109278 ↗

Phase 2 Completed 1100 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to test the safety of a measles, mumps, and rubella study vaccine made from a new measles stock seed (a component of the vaccine made in 2003) with rHA (recombinant human albumin).

Timeline

Start
2004-10
Primary completion
2005-05
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Measles, Mumps, and Rubella Virus Vaccine Live Vaccine — —
Subject V205C Vaccine — —

Indications